FARINI, ANDREA
FARINI, ANDREA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Advancing Biomarker Discovery and Therapeutic Targets in Duchenne Muscular Dystrophy: A Comprehensive Review
2024 M. Molinaro, Y. Torrente, C. Villa, A. Farini
Flvcr1a deficiency promotes heme-based energy metabolism dysfunction in skeletal muscle
2024 M. Mistretta, V. Fiorito, A.L. Allocco, G. Ammirata, M.Y. Hsu, S. Digiovanni, M. Belicchi, L. Napoli, M. Ripolone, E. Trombetta, P. Mauri, A. Farini, M. Meregalli, C. Villa, P.E. Porporato, B. Miniscalco, S.G. Crich, C. Riganti, Y. Torrente, E. Tolosano
Multifaceted nanoparticles: emerging mechanisms and therapies in neurodegenerative diseases
2023 M. Mistretta, A. Farini, Y. Torrente, C. Villa
Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin‐deficient mice
2022 A. Farini, L. Tripodi, C. Villa, F. Strati, A. Facoetti, G.A. Baselli, J. Troisi, A. Landolfi, C. Lonati, D. Molinaro, M. Wintzinger, S. Gatti, B. Cassani, F.A. Caprioli, F. Facciotti, M. Quattrocelli, Y. Torrente
Inhibition of the immunoproteasome modulates innate immunity to ameliorate muscle pathology of dysferlin-deficient BlAJ mice
2022 A. Farini, L. Tripodi, C. Villa, F. Napolitano, F. Strati, D. Molinaro, F. Facciotti, B. Cassani, Y. Torrente
The immune system in duchenne muscular dystrophy pathogenesis
2021 L. Tripodi, C. Villa, D. Molinaro, Y. Torrente, A. Farini
Role of Immunoglobulins in Muscular Dystrophies and Inflammatory Myopathies
2021 A. Farini, C. Villa, L. Tripodi, M. Legato, Y. Torrente
Defective dystrophic thymus determines degenerative changes in skeletal muscle
2021 A. Farini, C. Sitzia, C. Villa, B. Cassani, L. Tripodi, M. Legato, M. Belicchi, P. Bella, C. Lonati, S. Gatti, M. Cerletti, Y. Torrente
Myogenic Cell Transplantation in Genetic and Acquired Diseases of Skeletal Muscle
2021 O. Boyer, G. Butler-Browne, H. Chinoy, G. Cossu, F. Galli, J.B. Lilleker, A. Magli, V. Mouly, R.C.R. Perlingeiro, S.C. Previtali, M. Sampaolesi, H. Smeets, V. Schoewel-Wolf, S. Spuler, Y. Torrente, F. Van Tienen, H. Aldearee, A. Bisson, L. Bragg, V. Bridoux, R. Duelen, A. Farini, E. Gazzero, N. Giarratana, C. Giverne, L. Meggiolaro, E. Negroni, E. Porrello, R. Tonlorenzi, C. Villa, L. Yedigaryan, A. Zamboni
Blockade of IGF2R improves muscle regeneration and ameliorates Duchenne muscular dystrophy
2020 P. Bella, A. Farini, S. Banfi, D. Parolini, N. Tonna, M. Meregalli, M. Belicchi, S. Erratico, P. D’Ursi, F. Bianco, M. Legato, C. Ruocco, C. Sitzia, S. Sangiorgi, C. Villa, G. D’Antona, L. Milanesi, E. Nisoli, P. Mauri, Y. Torrente
Role of Insulin-Like Growth Factor Receptor 2 across Muscle Homeostasis: Implications for Treating Muscular Dystrophy
2020 Y. Torrente, P. Bella, L. Tripodi, C. Villa, A. Farini
Impact of Muscular Dystrophy on the Regenerative Properties of interstitial Muscle Cells
2019 M.L.C. Belicchi, M.A. Meregalli, S.A. Erratico, A. Cattaneo, C. Villa, A. Farini, L. Porretti, Y. Torrente
Preliminary evidences of safety and efficacy of flavonoids- and omega 3-based compound for muscular dystrophies treatment: a randomized double-blind placebo controlled pilot clinical trial.
2019 C. Sitzia, M. Meregalli, M. Belicchi, A. Farini, M. Arosio, D. Bestetti, C. Villa, L. Valenti, P. Brambilla, Y. Torrente
Exome sequencing identifies variants in two genes encoding the LIM-proteins NRAP and FHL1 in an Italian patient with BAG3 myofibrillar myopathy
2016 F. D’Avila, M. Meregalli, S. Lupoli, M. Barcella, A. Orro, F. DE SANTIS, C. Sitzia, A. Farini, P. D’Ursi, S. Erratico, R. Cristofani, L. Milanesi, D. Braga, D. Cusi, A. Poletti, C. Barlassina, Y. Torrente
Inositol 1,4,5-trisphosphate (IP3)-dependent Ca2+ signaling mediates delayed myogenesis in Duchenne muscular dystrophy fetal muscle
2016 A. Farini, C. Sitzia, L. Cassinelli, F. Colleoni, D. Parolini, U. Giovanella, S. Maciotta, A. Colombo, M. Meregalli, Y. Torrente
Stem cell-mediated exon skipping of the dystrophin gene by the bystander effect
2015 M. Meregalli, A. Farini, C. Sitzia, C. Beley, P. Razini, L.M. Cassinelli, F. Colleoni, P. Frattini, N. Santo, E. Galbiati, D. Prosperi, A. Tavelli, M. Belicchi, L. Garcia, Y. Torrente
Full-Length Dysferlin Expression Driven by Engineered Human Dystrophic Blood-Derived CD133+ Stem Cells
2014 M. Meregalli, C. Navarro, C. Sitzia, A. Farini, P. Razini, C. Beley, L. Cassinelli, D. Parazzoli, Y. Torrente
Improvement of endurance of DMD animal model using natural polyphenols
2014 S.E. Erratico, C. Sitzia, A. Farini, F. Colleoni, P. Razini, F. Fortunato, F. Fabrizi, M. Belicchi, M. Meregalli, G. Comi, Y. Torrente
Stem cell-mediated exon skipping of the dystrophin gene by the bystander effect
2014 Y. Torrente, M. Meregalli, C. Beley, A. Farini, C. Sitzia, P. Razini, L. Cassinelli, F. Colleoni, A. Tavelli, M. Belicchi, L. Garcia
Clinical applications of mesenchymal stem cells in chronic diseases
2014 A. Farini, C. Sitzia, S. Erratico, M.A. Meregalli, Y. Torrente